Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Type B Immunisation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT01362517
What this trial is testing

Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 131
Large-scale testing (Phase 3)Study completedNCT01917357
What this trial is testing

A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 400
Testing effectiveness (Phase 2)Study completedNCT04398706
What this trial is testing

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Who this might be right for
Pneumococcal ImmunisationDiphtheria ImmunisationTetanus Immunisation+8 more
Sanofi Pasteur, a Sanofi Company 852
Testing effectiveness (Phase 2)Study completedNCT00129129
What this trial is testing

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 756
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Testing effectiveness (Phase 2)Study completedNCT01248884
What this trial is testing

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Who this might be right for
TetanusPoliomyelitisHepatitis B+3 more
GlaxoSmithKline 721
Post-approval studies (Phase 4)Study completedNCT04535037
What this trial is testing

Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

Who this might be right for
Diphtheria
GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Large-scale testing (Phase 3)Study completedNCT00289783
What this trial is testing

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,441
Large-scale testing (Phase 3)Study completedNCT00259337
What this trial is testing

Immunogenicity and Safety of Pentaxim™ in an Indian Population

Who this might be right for
DiphtheriaTetanusPolio+2 more
Sanofi 226
Post-approval studies (Phase 4)Study completedNCT03530124
What this trial is testing

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

Who this might be right for
ApneaApnea NeonatalPrematurity
Duke University 223
Large-scale testing (Phase 3)Study completedNCT00228917
What this trial is testing

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Who this might be right for
Whole Cell PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 798
Testing effectiveness (Phase 2)Ended earlyNCT00871741
What this trial is testing

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Who this might be right for
TetanusPoliomyelitisNeisseria Meningitidis+4 more
GlaxoSmithKline 16
Large-scale testing (Phase 3)Study completedNCT00891176
What this trial is testing

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 582
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Not applicableStudy completedNCT01878435
What this trial is testing

Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Johns Hopkins Bloomberg School of Public Health 2,018
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Large-scale testing (Phase 3)Study completedNCT00136604
What this trial is testing

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Who this might be right for
Whole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more
GlaxoSmithKline 617